Gastrointestinal Cancers

Share

Program Content

Activities

  • Sidedness is Important in mCRC
    Tumor Location Prognostic and Predictive in KRAS wt mCRC: Retrospective Analysis of CALGB/SWOG 80405
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2016

    Expires: June 07, 2017

  • Pembrolizumab in MMRD CRC
    Pembrolizumab Shows Promising Activity in Mismatch Repair–Deficient CRC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2016

    Expires: June 08, 2017

  • MEK/PD-L1 Combo in mCRC
    Cobimetinib + Atezolizumab Well Tolerated and Shows Promising Activity in KRAS-Mutant mCRC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 10, 2016

    Expires: June 09, 2017

  • TAS-102 in mCRC
    Trifluridine/Tipiracil (TAS-102) Improves Survival in Patients With Metastatic CRC and Mild Renal/Hepatic Impairment: Subgroup Analysis of RECOURSE
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 13, 2016

    Expires: June 12, 2017

  • Immunoscore in CRC
    Immunoscore Prognostic in Colon Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 14, 2016

    Expires: June 13, 2017

  • GEMCAP vs CAP in Pancreatic Cancer
    ESPAC-4: Adjuvant Gemcitabine/Capecitabine Improves 5-Yr Survival vs Gemcitabine Alone in Resected Pancreatic Ductal Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 14, 2016

    Expires: June 13, 2017

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Ariad

Bayer Healthcare Pharma

Celgene

Genentech Roche Virology

Incyte

Merck Oncology

Taiho Pharmaceuticals